Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching (2020)
- Authors:
- USP affiliated authors: SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; LEON, ELAINE PIRES - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1007/s10067-019-04798-6
- Subjects: ANTICORPOS; CINÉTICA; FATORES DE RISCO; METOTREXATO; PACIENTES
- Agências de fomento:
- Nucleo de Apoio a Pesquisa ""Saude da Crianca e do Adolescente"" da USP (NAP-CriAd)
- Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for Scientific and Technological Development (CNPq) [CNPq 303422/2015-7, 305068/2014-8]
- Fundacao deAmparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP 2015/03756-4]
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical rheumatology
- ISSN: 0770-3198
- Volume/Número/Paginação/Ano: v. 39, n. 2, p. 515-521, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BRUNELLI, Juliana Barbosa et al. Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching. Clinical rheumatology, v. 39, n. 2, p. 515-521, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10067-019-04798-6. Acesso em: 13 fev. 2026. -
APA
Brunelli, J. B., Silva, C. A. A. da, Pasoto, S. G., Saa, C. G. S., Kozu, K. T., Goldenstein-Schainberg, C., et al. (2020). Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching. Clinical rheumatology, 39( 2), 515-521. doi:10.1007/s10067-019-04798-6 -
NLM
Brunelli JB, Silva CAA da, Pasoto SG, Saa CGS, Kozu KT, Goldenstein-Schainberg C, Leon EP, Vendramini MBG, Fontoura N, Bonfa ESD de O. Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching [Internet]. Clinical rheumatology. 2020 ; 39( 2): 515-521.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10067-019-04798-6 -
Vancouver
Brunelli JB, Silva CAA da, Pasoto SG, Saa CGS, Kozu KT, Goldenstein-Schainberg C, Leon EP, Vendramini MBG, Fontoura N, Bonfa ESD de O. Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching [Internet]. Clinical rheumatology. 2020 ; 39( 2): 515-521.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10067-019-04798-6 - Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control
- Is uric acid level a predictor of long-term renal outcome in lupus nephritis?
- Antibodies to cellular prion protein and its cognate ligand stress-inducible protein 1 in systemic lupus erythematosus
- Characterizing hand and wrist ultrasound pattern in primary Sjogren's syndrome: a case-control study
- Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity
- Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting
- Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country
- 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity
Informações sobre o DOI: 10.1007/s10067-019-04798-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
